Enhancing Prephenate Dehydratase Activity for L-Tryptophan Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing L-tryptophan using recombinant strains face challenges such as difficulty in controlling phenylalanine and tyrosine levels, increased production costs, and low solubility issues, which hinder maximizing L-tryptophan yield due to competing metabolic pathways and byproduct accumulation.
Innovation Solution
Enhancing prephenate dehydratase (PheA) activity in Corynebacterium strains to optimize metabolic flux between phenylalanine and tyrosine, allowing for controlled amino acid production and reduced anthranilate accumulation, thereby increasing L-tryptophan yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If phenylalanine or tyrosine pathway is deleted or weakened to maximize L-tryptophan production, then L-tryptophan yield is improved, but difficulty in controlling feeding amounts of phenylalanine and tyrosine arises
Solution Approach 1:
The patent extracts and eliminates the competing phenylalanine and tyrosine pathways from the metabolic network by using a Corynebacterium strain that naturally lacks these pathways. This allows the cell to dedicate all metabolic flux toward L-tryptophan production without the operational complexity of managing multiple amino acid feedings.
Solution Approach 2:
The patent employs a universal strain background (Corynebacterium glutamicum) that inherently lacks both phenylalanine and tyrosine synthesis pathways, allowing simultaneous production of L-tryptophan and tyrosine as a byproduct without requiring separate pathway control systems.
2Productivity
If phenylalanine or tyrosine pathway is deleted or weakened to maximize L-tryptophan production, then L-tryptophan yield is improved, but additional cost increases
Solution Approach 1:
The patent removes the need for complex media preparation and additional amino acid supplementation by using a strain that naturally lacks phenylalanine and tyrosine pathways, thereby reducing manufacturing complexity and cost while maintaining high L-tryptophan yield.
3Productivity
If phenylalanine or tyrosine pathway is deleted or weakened to maximize L-tryptophan production, then L-tryptophan yield is improved, but difficulty in preparing main and feed media arises
Solution Approach 1:
The patent eliminates the need to prepare and manage multiple amino acid supplements (phenylalanine and tyrosine) by using a strain that naturally lacks the competing pathways, simplifying media preparation to a single L-tryptophan production system.
4Productivity
If Corynebacterium strain produces L-tryptophan at high yield without deleting phenylalanine or tyrosine pathway, then L-tryptophan yield is improved, but anthranilate accumulates in the latter stage of culture
Solution Approach 1:
The patent changes the metabolic flux parameters by enhancing prephenate dehydratase activity, which redirects metabolic flow away from anthranilate formation toward L-tryptophan production, eliminating the harmful byproduct accumulation while maintaining high yield.
Solution Approach 2:
The patent converts the potentially harmful anthranilate accumulation issue into a benefit by using the same metabolic pathway (prephenate dehydratase) that produces L-tryptophan to simultaneously suppress anthranilate formation, turning a problem into a solution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The enhanced PheA activity in Corynebacterium strains minimizes anthranilate production and significantly improves L-tryptophan yield, achieving a higher fermentation output with controlled amino acid levels and reduced production costs.
Implementation Method 1
enhancement of prephenate dehydratase (PheA) activity
Implementation Method 2
direct fermentation using microorganisms is mainly used for the production of L-tryptophan
Data Source
AI summary
The present disclosure relates to a method for producing L-tryptophan through the enhancement of prephenate dehydratase (PheA) activity.